Cramer now sees value in drug stock Valeant after its CEO 'delivered'
June 06, 2018 at 11:57 AM EDT
Jim Cramer mentions a positive note by Barclays analyst Douglas Tsao on Wednesday regarding Valeant Pharmaceuticals.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|